Dalan, Maribel R.

HRN: 03-01-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
CEFTRIAXONE 1G (VIAL)
05/09/2023
05/16/2023
IV
2 Grams
OD
Typhoid Fever
Waiting Final Action 
05/15/2023
METRONIDAZOLE 500MG (TAB)
05/15/2023
05/21/2023
PO
500mg
BID
H. Pylori Infection
Waiting Final Action 
05/15/2023
CLARITHROMYCIN 500MG (CAP)
05/15/2023
05/21/2023
PO
500mg
BID
H. Pylori Infection
Waiting Final Action 
06/15/2023
CEFTRIAXONE 1G (VIAL)
06/15/2023
06/21/2023
IV
2g
Od
Wbc 39.6, T/c UTI, T/c Leprosy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: